Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
Active, not recruiting · NCT03324425 · Registry updated 2025-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2025-02-27 | NCT03324425 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor Breast Care Center | 3 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harris Health System - Smith Clinic | Houston | United States | 6 |
| O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center | Houston | United States | 1 |